This kind of blatant ramping cannot go unchallenged.
“all the heavy expenditure on research has been done” – where is your evidence for that? Are you in a position to even know what levels of research are required, let alone what has actually been done.
“clinical trials scheduled soon ( PHASE I)” – really, for when are they scheduled? Are you aware that IND approval is required BEFORE Phase I trials can be approved. Has RCE received IND approval? Has it even filed for IND?
Do you have any idea how much Phase I trials cost (Hint: WAY MORE than the current capital raising).
“and getting the respective FDA and TGA approvals through” – you’re kidding, right? FDA approval follows Phase III trials – we are talking upwards of 5 years on the fast track – IF everything goes smoothly and IF they get IND approval.
“SAS already granted” – for what, and why would that put a rocket” up anything.
“Rce has already been awarded fast track FDA (qdip)” – so what? Any new drug that meets the criteria of: 1) treats serious or life-threatening conditions and, 2) demonstrates the potential to address unmet medical needs, qualifies for fast tracking. All a company has to do is meet those criteria and file a QDIP application.
“so unlike many other bio's the time frame here from go to woah is much contracted” - how and why? Any competing technology can file for the same status – where is RCE’s advantage?
And to top it all, you have the audacity to say “I’m hearing closed before it really opened” and urging people to rush in – so you have inside information? Do tell, we would all appreciate hearing who your source is.
You are free to invest in any company whose “fantastic product” you “really like” - just don’t make unsubstantiated, distortions of the facts, for what is clearly, your own self-interest.
- Forums
- ASX - By Stock
- RCE
- Capital Raise
Capital Raise, page-10
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
61.5¢ |
Change
-0.005(0.81%) |
Mkt cap ! $125.4M |
Open | High | Low | Value | Volume |
62.0¢ | 63.5¢ | 61.5¢ | $4.678K | 7.558K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 4783 | 61.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
63.5¢ | 11803 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4771 | 0.615 |
5 | 61233 | 0.600 |
1 | 30000 | 0.595 |
4 | 101949 | 0.590 |
1 | 50000 | 0.585 |
Price($) | Vol. | No. |
---|---|---|
0.635 | 11803 | 1 |
0.640 | 50000 | 1 |
0.645 | 50629 | 2 |
0.650 | 34260 | 1 |
0.655 | 6970 | 1 |
Last trade - 10.44am 15/05/2024 (20 minute delay) ? |
|
|||||
Last
63.0¢ |
  |
Change
-0.005 ( 0.79 %) |
|||
Open | High | Low | Volume | ||
61.5¢ | 63.0¢ | 61.5¢ | 8329 | ||
Last updated 12.26pm 15/05/2024 ? |
Featured News
RCE (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O’Donovan, Executive Director
Gerard O’Donovan
Executive Director
SPONSORED BY The Market Online